David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.52B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.43B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$798M |
| 4 |
Amazon
AMZN
|
+$646M |
| 5 |
Texas Instruments
TXN
|
+$619M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.31B |
| 2 |
Broadcom
AVGO
|
+$1.01B |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$863M |
| 4 |
Western Digital
WDC
|
+$595M |
| 5 |
Meta Platforms (Facebook)
META
|
+$591M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.6% |
| 2 | Consumer Discretionary | 9.12% |
| 3 | Healthcare | 7.62% |
| 4 | Industrials | 7.14% |
| 5 | Financials | 6.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Evertec
EVTC
$1.78B
| $20.2M | 0.01% |
694,723
+255,920
| +58% | +$7.6M |
|
1152
Teva Pharmaceuticals
TEVA
$44.1B
| $20.2M | 0.01% |
647,111
+477,944
| +283% | +$11.8M |
|
1153
Rithm Capital
RITM
$5.64B
| $20.2M | 0.01% |
1,849,410
+334,996
| +22% | +$3.7M |
|
|
NTST
1154
NETSTREIT Corp
NTST
$2.11B
| $20.1M | 0.01% |
1,141,726
+368,371
| +48% | +$6.71M |
|
1155
CrowdStrike
CRWD
$193B
| $20.1M | 0.01% |
171,448
-183,196
| -52% | -$23.3M |
|
1156
PUT
Cenovus Energy
CVE
$58B
| $20.1M | 0.01% |
1,187,300
+280,000
| +31% | +$4.86M |
|
1157
Otter Tail
OTTR
$3.88B
| $20.1M | 0.01% |
248,239
-11,773
| -5% | -$954K |
|
1158
Sprouts Farmers Market
SFM
$8.07B
| $20.1M | 0.01% |
251,759
-1,416,997
| -85% | -$127M |
|
1159
CALL
Dow Inc
DOW
$21.9B
| $20M | 0.01% |
857,300
+40,900
| +5% | +$940K |
|
1160
Clear Secure
YOU
$4.59B
| $20M | 0.01% |
570,970
-95,875
| -14% | -$3.26M |
|
1161
TETRA Technologies
TTI
$1B
| $20M | 0.01% |
2,136,547
+499,698
| +31% | +$3.86M |
|
1162
ANI Pharmaceuticals
ANIP
$1.7B
| $20M | 0.01% |
253,536
+40,530
| +19% | +$3.51M |
|
|
EXE
1163
PUT
Expand Energy Corp
EXE
$22.4B
| $20M | 0.01% |
181,300
+16,900
| +10% | +$1.87M |
|
1164
CALL
CRISPR Therapeutics
CRSP
$5.75B
| $20M | 0.01% |
381,100
+20,800
| +6% | +$1.25M |
|
1165
Cohen & Steers
CNS
$4.29B
| $20M | 0.01% |
317,876
+141,529
| +80% | +$9.21M |
|
1166
CALL
Blackrock
BLK
$183B
| $19.9M | 0.01% |
18,600
+4,100
| +28% | +$4.48M |
|
1167
Concentrix
CNXC
$1.68B
| $19.9M | 0.01% |
478,632
+376,136
| +367% | +$15.3M |
|
1168
Ferguson
FERG
$45.7B
| $19.9M | 0.01% |
89,231
-578,085
| -87% | -$138M |
|
1169
CALL
Constellation Brands
STZ
$23.1B
| $19.9M | 0.01% |
143,900
+117,000
| +435% | +$16.1M |
|
1170
ABM Industries
ABM
$2.79B
| $19.8M | 0.01% |
468,809
+276,510
| +144% | +$12.1M |
|
1171
Sysco
SYY
$40B
| $19.8M | 0.01% |
268,450
-172,708
| -39% | -$13.1M |
|
1172
Leggett & Platt
LEG
$1.26B
| $19.7M | 0.01% |
1,794,694
-1,188,944
| -40% | -$11.7M |
|
1173
Sanmina
SANM
$10.8B
| $19.7M | 0.01% |
131,068
-211,046
| -62% | -$31.2M |
|
1174
RxSight
RXST
$270M
| $19.6M | 0.01% |
1,883,829
+49,938
| +3% | +$501K |
|
1175
CALL
Rubrik
RBRK
$19.9B
| $19.6M | 0.01% |
256,600
+11,800
| +5% | +$905K |
|
Similar funds
David Shaw's Q4 2025 Portfolio in Review
As of Q4 2025, David Shaw held 5,141 positions worth $182B, up 3% from $177B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2025 filing shows 639 new, 1,734 increased, 1,574 reduced and 583 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 1,175,000 shares worth $805M. The largest sale was Micron Technology, an estimated $1.31B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2025 buy was iShares Core S&P 500 ETF: 1,175,000 shares worth $805M.
- David Shaw added most to Advanced Micro Devices in Q4 2025, an estimated $1.52B increase.
- David Shaw's biggest Q4 2025 reduction was Micron Technology, cutting an estimated $1.31B.
- David Shaw fully exited Vanguard Short-Term Corporate Bond ETF in Q4 2025, selling an estimated $499M.
- David Shaw's ten largest holdings make up 12% of its $182B portfolio in Q4 2025.
- David Shaw opened 639 new positions and closed 583 in Q4 2025.
- David Shaw's portfolio value rose 3% quarter-over-quarter to $182B.
Based on D.E. Shaw & Co's 13F filing for Q4 2025, filed 17 Feb 2026.